CDT Equity issued 12,131,122 common shares after investors exercised all pre-funded warrants on a cashless basis. The company had 13,693,866 shares outstanding as of August 31, while its stated market Capitalization was approximately $23.0 million. CDT Equity said it no longer had outstanding deficiencies with Nasdaq.
Key Highlights
- Pre-funded warrants covered the potential purchase of 12,131,770 common shares.
- CDT Equity’s common stock carried a Par Value of $0.0001 per share.
- Stockholders approved the share issuance at the August 28, 2026 annual meeting.
The company said the transactions resulted in no remaining deficiencies with The Nasdaq Stock Market LLC.
12.1M-Share Warrant Conversion Completed
Stockholders approved the common-stock issuance at the August 28, 2026 annual meeting. The pre-funded warrants were issued to certain stockholders of Sarborg Limited under a July 30, 2026 Securities Purchase Agreement and covered the purchase of 12,131,770 shares. The warrants were exercised in full without a cash payment, resulting in the issuance of 12,131,122 common shares. The stock has a par value of $0.0001 per share. James Bligh signed on behalf of CDT Equity (NASDAQ: CDT) on September 1 as chief executive officer and chief financial officer.
$23.0M Market Capitalization and Nasdaq Status
Based on the August 31 closing price of its common stock, CDT Equity’s market capitalization was approximately $23.0 million. Stockholders’ equity was approximately $103 million in the Quarterly Report for the quarter ended June 30, 2026. The company said it therefore no longer had any outstanding deficiencies with Nasdaq.
FAQs
Q: How many shares did CDT Equity issue after the warrant exercise?
A: CDT Equity issued 12,131,122 common shares after investors exercised all pre-funded warrants on a cashless basis. The company had 13,693,866 shares outstanding as of August 31.
Q: What was CDT Equity’s market capitalization?
A: CDT Equity’s market capitalization was approximately $23.0 million based on its common-stock closing price on August 31. Stockholders’ equity was approximately $103 million for the quarter ended June 30, 2026.
Q: Did CDT Equity resolve its Nasdaq deficiencies?
A: Yes. CDT Equity said it no longer had any outstanding deficiencies with The Nasdaq Stock Market LLC after the warrant exercise and other recent issuances.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.